INVEGA Trademark

Trademark Overview

On Monday, November 14, 2005, a trademark application was filed for INVEGA with the United States Patent and Trademark Office. The USPTO has given the INVEGA trademark a serial number of 76650290. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, October 5, 2017. This trademark is owned by JOHNSON & JOHNSON. The INVEGA trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical for the treatment of Central Nervous System Diseases
invega

General Information

Serial Number76650290
Word MarkINVEGA
Filing DateMonday, November 14, 2005
Status800 - REGISTERED AND RENEWED
Status DateThursday, October 5, 2017
Registration Number3344746
Registration DateTuesday, November 27, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 4, 2006

Trademark Statements

Goods and ServicesHuman pharmaceutical for the treatment of Central Nervous System Diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 22, 2005
Primary Code005
First Use Anywhere DateWednesday, January 3, 2007
First Use In Commerce DateWednesday, January 3, 2007

Trademark Owner History

Party NameJOHNSON & JOHNSON
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001
Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001

Trademark Events

Event DateEvent Description
Thursday, October 5, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, October 5, 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, October 5, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, October 5, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 1, 2017TEAS SECTION 8 & 9 RECEIVED
Sunday, November 27, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, May 20, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 20, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, December 1, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, December 1, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, November 20, 2013REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Sunday, December 1, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 20, 2013TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 19, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 27, 2007REGISTERED-PRINCIPAL REGISTER
Thursday, October 25, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, October 25, 2007ASSIGNED TO LIE
Tuesday, September 25, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 24, 2007STATEMENT OF USE PROCESSING COMPLETE
Monday, April 30, 2007USE AMENDMENT FILED
Monday, April 30, 2007TEAS STATEMENT OF USE RECEIVED
Monday, March 26, 2007EXTENSION 1 GRANTED
Monday, March 26, 2007EXTENSION 1 FILED
Monday, March 26, 2007TEAS EXTENSION RECEIVED
Tuesday, September 26, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 4, 2006PUBLISHED FOR OPPOSITION
Wednesday, June 14, 2006NOTICE OF PUBLICATION
Wednesday, May 17, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 12, 2006ASSIGNED TO LIE
Wednesday, May 10, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 10, 2006ASSIGNED TO EXAMINER
Tuesday, November 22, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

invega system diseases nervous central pharmaceutical treatment human